⚡ Testosterone & the male hormonal axis
5 mechanistic pathways · 63 options
The axis is a loop: hypothalamus → pituitary → testes → testosterone → feedback. You can intervene at any point, and where you intervene determines what you keep. Suppress the loop from the top and you get testosterone without fertility; stimulate it from the top and you keep both. Test before you treat. Total testosterone, free testosterone, LH, FSH, SHBG, estradiol and prolactin — a symptom picture alone cannot tell you which part of the loop is broken.
The pathways
Upstream stimulation — keeping the axis running
Everything here raises your own production rather than replacing it. That preserves fertility, testicular volume and the ability to come off. It is also the pathway that fails when the testes themselves are the problem — which is what LH and FSH tell you.
Aromatase & estrogen management
Testosterone converts to estradiol via aromatase, mostly in fat tissue. Men need estradiol — for libido, bone, lipids and mood — so this is a U-shaped curve and not a lower-is-better one. More harm is done here by overcorrection than by high estrogen.
SHBG & free testosterone
Only a small fraction of circulating testosterone is bioavailable — the rest is bound to SHBG. Normal total testosterone with high SHBG produces every symptom of low testosterone and a lab report that looks fine. This is the most commonly missed pattern in the whole axis.
5-alpha-reductase, DHT & the hair trade-off
DHT is testosterone's more potent metabolite — responsible for libido and prostate growth and male-pattern hair loss. Blocking it protects hair and prostate and can cost you libido and mood. There is no free lunch on this pathway, and pretending otherwise is how people get hurt.
Recovering the axis — post-cycle and post-TRT
Exogenous testosterone shuts down LH and FSH. Restarting means reactivating the pituitary and re-sensitizing the testes, and the order matters — waking a pituitary whose testes have atrophied achieves nothing.
Test before you choose a pathway
Every route below can be argued for on mechanism. Only bloodwork tells you which one is actually your problem — and picking the wrong pathway is the most common reason someone concludes "none of this works". Across all 5 pathways, these are the 14 markers worth having in front of you first.
Ordered together:
🔍 Low T? Rule Out the Reversible Causes First🔄 TRT Monitoring📋 Pre-TRT Baseline💇 Hair Panel — Comprehensive🔄 Post-Cycle / Recovery & FertilityWhat actually decides this outcome, in order of size
Two men with the same total testosterone can need opposite things, and which one you are is settled by three numbers that cost the same as the one everybody orders. Ranked by how much of the outcome each one owns:
- Whether the testes or the pituitary is the problem, because that decides the entire page. LH & FSH is what separates them. High gonadotropins with a low testosterone is primary testicular failure and no amount of upstream stimulation will fix it; low or inappropriately normal gonadotropins is a secondary problem and is the situation the whole of Upstream stimulation — keeping the axis running is written for. Clinical practice guidance treats this distinction as the first branch point Bhasin 2018.
- The binding protein, because it decides how much of the number is available. SHBG (Sex Hormone-Binding Globulin) varies with insulin, thyroid status, alcohol, age and liver function, and a normal Total Testosterone with a high binding protein produces every symptom of a low one with a lab report that reads as fine Szybiak-Skora 2025. That pattern is the subject of SHBG & free testosterone and it is the most commonly missed thing on this goal.
- Whether the number is even real, which is a question about sampling rather than about you. Testosterone has a diurnal peak in the morning and meaningful within-person biological variation, quantified formally as part of a European biological variation study Itkonen 2024. One afternoon draw after a bad week is not a diagnosis; two morning draws are the minimum the guideline asks for Bhasin 2018.
- What the number was ever supposed to predict. Raising testosterone raises testosterone. Whether treating it changes a hard outcome had to be tested separately, and the cardiovascular safety question specifically required a dedicated randomized trial to answer Lincoff 2023. That is the shape of the gap between a level and an endpoint, and it is the reason this hub does not treat a number as a goal.
- What you want to keep. Exogenous testosterone suppresses the axis, and intratesticular concentrations are what fertility depends on. Low-dose human chorionic gonadotropin was shown to maintain those concentrations in men receiving testosterone Coviello 2005, which is why fertility is a planning decision made before the first injection rather than a problem solved after it.
- The compounds, last, and the herbal half is a repletion story. Eurycoma has a systematic review and meta-analysis in men Leisegang 2022; zinc status and testosterone were linked in work on deficiency rather than on surplus Prasad 1996; purified shilajit has a testosterone trial Pandit 2016 and unpurified resin has a heavy-metal problem serious enough to have been quantified Kamgar 2025.
The order to run these in, and what has to be true first
Two morning draws, then the branch point, then the pathway. Nothing below is ordered by evidence tier; it is ordered by what has to be known before the next step can be chosen.
- Two morning draws, fasting, on separate days. Total Testosterone and SHBG (Sex Hormone-Binding Globulin) on both. One requisition also carries LH & FSH, Estradiol, Sensitive (LC/MS-MS), Prolactin, Complete Blood Count (CBC) with Differential, HbA1c (Hemoglobin A1c), Ferritin, TSH (Thyroid-Stimulating Hormone) and, over forty, PSA (Total + Free + % Free). Two draws because of documented within-person variation Itkonen 2024; the sensitive estradiol assay because the standard immunoassay is not reliable at male concentrations.
- Fix the four things that suppress the axis for free before treating it. Short sleep, untreated sleep apnea, heavy alcohol and a large energy surplus each lower testosterone, and all four are outside this shelf. Snoring with daytime sleepiness in a man with low testosterone is a sleep study, not a prescription.
- Read LH & FSH and take the branch. Gonadotropins high means the testes are the limit and replacement is the honest conversation; gonadotropins low or normal means Upstream stimulation — keeping the axis running, where Enclomiphene has pharmacodynamic and clinical data in secondary hypogonadism Wiehle 2013 and a position statement on its potential use Foster 2026.
- If total is adequate and symptoms persist, the binding protein is the next suspect. SHBG & free testosterone, where Boron, Nettle Root and Tongkat Ali sit. Calculate free testosterone rather than assuming it, and know that the equations disagree with each other and with equilibrium dialysis in a way that depends on the binding protein itself Hackbarth 2011.
- Estrogen management only if there is a symptom, never on a number alone. Aromatase & estrogen management. Aromatase inhibition in older men with low testosterone raises testosterone and lowers estradiol Leder 2004; men need estradiol for bone, lipids, mood and libido, so this is a U-shaped curve. Letrozole and Anastrozole are the potent end of it and are the easiest way on this entire goal to make somebody feel worse while improving their ratio.
- The hair and prostate trade-off is a separate decision with its own page. 5-alpha-reductase, DHT & the hair trade-off, and the follicle-side version of the same argument is Hair — follicle biology & the androgen problem.
- Coming off is a protocol, not an event. Recovering the axis — post-cycle and post-TRT, and the reason HCG is used before the pituitary is stimulated is that a pituitary signal reaching an atrophied testis achieves nothing Coviello 2005.
What gets bought for this that cannot move it
The category that fails structurally is the test booster bought by a man whose testosterone is normal. The herbal evidence on this goal is repletion and rescue evidence: eurycoma performs best in stressed and subfertile men Leisegang 2022, and the zinc relationship was established through deficiency Prasad 1996. Adding a cofactor to somebody who already has enough of it is not a smaller effect, it is a different one, and it is usually zero. That is a testable claim: order Zinc, RBC before buying zinc for this purpose.
The second failure is treating estradiol as a number to minimize. Aromatase inhibition does exactly what it says Leder 2004, and the men who feel worst on this goal are frequently the ones whose estradiol was crushed to fix a result nobody had a symptom for. Order the sensitive assay, treat the symptom, and leave the ratio alone.
And there is a supply-side failure that is specific to this goal. Unpurified shilajit resin has been assayed for thallium content because contamination is a known problem in the category Kamgar 2025, and an unlicensed vial of anything on the prescription half of this goal has no assay behind the dose written on it. Purity is not a footnote here; it is the difference between the trial product and the one in your hand.
If the goal underneath is different, so is the page. Low libido with normal testosterone is a central rather than a hormonal problem and lives at Central desire — melanocortin & dopaminergic. Fatigue with normal testosterone is Energy & fatigue. Poor erections with normal testosterone is vascular and lives at Vascular & erectile function. And testosterone therapy is a long-term prescription with a monitoring schedule, not a supplement decision; the cardiovascular question alone needed a dedicated trial to settle Lincoff 2023.
How you would know it was working, on a real read-out and a real timescale
This page makes two predictions. Two morning Total Testosterone draws taken a week apart in an untreated man will differ by more than most readers expect, which is why one of them is not a decision Itkonen 2024; and on any effective upstream agent LH & FSH moves before testosterone does, because the pituitary signal is the mechanism and the gonadal response is the result.
- Total Testosterone with SHBG (Sex Hormone-Binding Globulin), morning, at baseline (twice) and at 6 to 8 weeks. Six weeks because the seminiferous and steroidogenic response to a changed gonadotropin signal is measured in weeks rather than days. Always the same laboratory and the same assay, because platform differences are larger than the change you are looking for.
- Free Testosterone calculated from the pair above, and read with the caveat attached. The published equations do not agree with each other or with dialysis across the binding-protein range Hackbarth 2011, so a calculated value is a tracking number for one person over time rather than a threshold.
- LH & FSH at baseline and 4 weeks on any upstream agent. Four weeks because this is the mechanism check: gonadotropins that have not moved mean the agent is not doing what it claims, regardless of how anybody feels Wiehle 2013.
- Estradiol, Sensitive (LC/MS-MS) at baseline and 8 weeks, and only acted on alongside a symptom. The standard immunoassay is not the test to use in men.
- Complete Blood Count (CBC) with Differential and PSA (Total + Free + % Free) at baseline, 3 months and then annually on any testosterone therapy. Hematocrit is the commonest reason a dose is reduced, and it rises on a slower schedule than the testosterone does, which is why the three-month draw exists Bhasin 2018.
What will fool you. Testosterone falls during acute illness, after poor sleep and in the second half of the day, so the draw conditions can manufacture the diagnosis. Biotin at supplement doses interferes with several hormone immunoassays. A change in weight changes the binding protein, which changes the free fraction without any change in production. Feeling better in the first fortnight of any of these agents is not evidence about the axis, because the axis has not had time to respond. And a raised estradiol in a man with a rising weight is usually adipose aromatase doing its job rather than an inhibitor being needed Leder 2004.
Sources read for these sections
- Bhasin S. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2018;103(5):1715-1744 · PMID 29562364
- Lincoff AM. Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine 2023 · PMID 37326322
- Hackbarth JS, et al. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids 2011 · PMID 20816687
- Szybiak-Skora W, et al. New Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)-Clinical Approach. Biomedicines 2025 · PMID 40427034
- Itkonen O, et al. The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men. Clinica Chimica Acta 2024 · PMID 38341016
- Wiehle R, Cunningham GR, Pitteloud N, Wike J, Hsu K, Fontenot GK, Rosner M, Dwyer A, Podolski J. Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics.. BJU Int 2013 · PMID 23875626
- Foster J, Choo L, Patel A, Kirby M, Hackett G. British Society of Sexual Medicine: Position Statement for the Potential Use of Enclomiphene in the Treatment of Male Hypogonadism.. World J Mens Health 2026 · PMID 41714894
- Coviello AD, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. Journal of Clinical Endocrinology and Metabolism 2005 · PMID 15713727
- Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.. J Clin Endocrinol Metab 2004 · PMID 15001605
- Leisegang K. Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials. Medicina (Kaunas) 2022;58(8):1047 · PMID 36013514
- Prasad AS, et al. Zinc status and serum testosterone levels of healthy adults. Nutrition, 1996 · PMID 8875519
- Pandit S, et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia 2016 · PMID 26395129
- Kamgar E, et al. Quantifying of thallium in Shilajit and its supplements to unveil the potential risk of consumption of this popular traditional medicine. BMC Chemistry 2025 · PMID 39827344
You have the pathways. Here is the stack.
The Testosterone Blueprint names the one compound I would start with in each of these 5 pathways, what it was chosen over, and why — plus 28 options to swap in or stack on top, every one of them priced and linked.
Open The Testosterone Blueprint →You know the goal. Skool has the plan.
Every pathway above is one arm of The Testosterone & the male hormonal axis Blueprint. The members' version has the sequence they run in, what stacks with what, and the markers that tell you to keep going or stop — alongside the Bloodwork Protocols.
Open The Testosterone & the male hormonal axis Blueprint in Skool →$10/mo, cancel anytime.
← Open Testosterone & the male hormonal axis in the interactive Vault · All 21 goals
Frequently asked questions
This goal is broken into 5 distinct mechanistic pathways — Upstream stimulation — keeping the axis running; Aromatase & estrogen management; SHBG & free testosterone; 5-alpha-reductase, DHT & the hair trade-off and others — across 63 compounds and supplements. Each pathway is a different argument about how the body gets there, so the useful question is which one matches where you are actually stuck.
The one that matches your actual limitation, which bloodwork usually settles faster than guessing. An appetite drug does nothing for someone who already undereats, and a thyroid intervention does nothing if your thyroid is fine. Each pathway page lists the markers that tell you whether it is your problem.
No. The 5 pathways are listed in mechanistic order, not by strength of evidence, and neither are the 63 options inside them. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for.
Where this goes next
Everything above is the free case for Testosterone & the male hormonal axis. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.